Thomas Aparicio
机构：Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Université de Lille, Saint Louis University Hospital, Centre Hospitalier Universitaire de Lille, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis · ORCID：0000-0001-8834-6927
发表论文 496 篇 · 总被引 13890 次 · h-index 56
代表论文
- PFMG2025–integrating genomic medicine into the national healthcare system in France (2025 · The Lancet Regional Health - Europe · 被引 54)
- Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors (2025 · JAMA Oncology · 被引 26)
- Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) (2024 · Journal of Clinical Oncology · 被引 21)
- Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials (2025 · British journal of surgery · 被引 14)
- Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma (2025 · Communications Medicine · 被引 13)
- Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases (2024 · British Journal of Cancer · 被引 12)